Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib and Bevacizumab Maintenance in Advanced NSCLC
NCT00425646Phase 2Completed
- Sponsor
- University of Washington
- Start
- Nov 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of imatinib in non-small cell lung cancer (NSCLC), sponsored by University of Washington. Primary endpoint: Progression-free survival. Started Nov 2006; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00425646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425646.